Blood Tests for SNCG and BCL6 as Markers of Endometriosis
Studies whether two blood proteins can help detect endometriosis without surgery.
Plain-language title generated from the registry record
Registry title: Biomarkers for Endometriosis
Key facts
- Where
- Toronto, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT07713797, who can take part
Where in Canada
- Trio FertilityToronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Trio Fertility
- Trial code
- NCT07713797
- Record updated
- 3 August 2026
- Original description
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy.Read full original descriptionShow less
A Prospective, Observational and Multicentric Study to Evaluate the Performance and Clinical Utility of EndoID ELISA Kit to Determine Circulating Synuclein Gamma (SNCG) and B-cell Lymphoma-6 (BCL6) Levels as Potential Biomarkers for Endometriosis"
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy.
The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Inclusion: Women of reproductive age group (18Y-45Y); Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy; Women of reproductive age group (18Y-45Y); Women without endometriosis and any other gynaecological problem.
Exclusion: Current or prior history of uterine, ovarian, colon, pancreatic, breast or any other type of cancer; Any prior history of chronic illness; Prior history of any disease including cancer or chronic illness; Women <18Y and >45Y; Women with endometriosis during stimulation with gonadotropins; Pregnant women; Women <18Y and >45Y; Pregnant women.